Business / Finance

RSS

NMS announces license agreement with Novartis

Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy and one of the leading oncology-focused, integrated discovery and development companies in Europe, today announced a license agreement with Novartis.

16 Mar 2011

Raymond Associates, BioNeutral enter global sales and distribution agreement for Ygiene antimicrobial technology

BioNeutral Group, Inc., a specialty life science technology-based company, today announced that it has entered into a global sales and distribution agreement with Raymond Associates LLC, a Service Connected Certified Disabled Veteran-Owned Business and executive management consulting firm.

15 Mar 2011

Omeros fourth quarter net loss increases to $7.2 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth quarter and year ended December 31, 2010.

15 Mar 2011

DJO Global signs definitive agreement to purchase Rikco for $254.6 million

DJO Global, Inc., a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that one of its indirect subsidiaries has signed a definitive agreement to purchase Rikco International, LLC, D/B/A Dr. Comfort, for approximately $254.6 million in cash.

15 Mar 2011

BioDrain retains CFSG1 as its U.S. Investor Relations representative

BioDrain Medical, Inc., producer of the FDA cleared Streamway System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 as its U.S. Investor Relations representative.

15 Mar 2011

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its financial results for its fourth quarter and the fiscal year ended December 31, 2010.

15 Mar 2011

Illumina prices 0.25% Convertible Senior Notes due 2016

Illumina, Inc. today announced the pricing of $800 million principal amount of 0.25% Convertible Senior Notes due 2016 through offerings to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

From Illumina, Inc. 15 Mar 2011

Medidata fourth quarter net revenue is $47.4 million for 2010

Medidata Solutions, a leading global provider of SaaS-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the fourth quarter 2010 and full year ended December 31, 2010, as well as provided financial guidance for the first quarter and full year 2011.

15 Mar 2011

Hanger Orthopedic Group amends existing Credit Agreement

Hanger Orthopedic Group, Inc. announced today that it has amended its existing Credit Agreement to lower the applicable interest rates and modify certain other covenants. The Amendment (i) reduces the interest rate margin applicable to the term loan under the Credit Agreement by 0.75% to 3.00% and (ii) reduces the LIBOR floor applicable to the term loan under the Credit Agreement from 1.50% to 1.00%.

14 Mar 2011

BioMed declares $0.20 first quarter dividend

BioMed Realty Trust, Inc. today announced that its board of directors has declared a first quarter 2011 dividend of $0.20 per share of common stock, representing a 17.6% increase over the company's fourth quarter 2010 dividend of $0.17 per share. The dividend is equivalent to an annualized dividend of $0.80 per common share.

14 Mar 2011

Milestone Scientific commences trading on OTCQB

Milestone Scientific Inc. which develops, manufactures, and markets computer-controlled injection systems for medical and dental markets, today announced that its common stock has commenced trading on the OTCQB(TM) electronic quotation and trading system under the ticker symbol MLSS.PK. Stockholders are not required to take any action as a result of the addition of the Company's securities to the OTCQB(TM).

14 Mar 2011

Air Techniques' Spectra device leads caries detection aid category in sales

Air Techniques, Inc., a leading dental equipment manufacturer, announced today that its Spectra device led the caries detection aid category in dollar sales with a 2010 market share of almost 50%. In addition, in the fourth quarter of 2010, Spectra for the first time also led the category in units sold, and it set a record with a dollar market share of over 60%.

14 Mar 2011

Gamida to distribute Health Robotics' CytoCare, i.v.STATION, i.v.SOFT technologies in Israel

Health Robotics today announced that it recently signed an exclusive distribution agreement for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies with Israel-based medical technology leader Gamida MedEquip Ltd.

14 Mar 2011

Omthera to fund Epanova Phase 3 development with $33.9 million in Series B funding

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that it has raised $33.9 million in a Series B funding round, led by new investor, New Enterprise Associates ("NEA"), one of the world's leading venture capital firms. Existing investor, Sofinnova Partners, also participated in the financing.

14 Mar 2011

Maricom opens third office in Lutherville

Maricom Systems, Inc. continues its expansion and growth as it announced today the opening of the company's third office in Lutherville, Maryland. The new location will support the company's Business Development and Healthcare IT sectors. Maricom's other locations are in Woodlawn, the corporate headquarters, and Annapolis Junction, the Office of Classified Programs.

14 Mar 2011

HemaCare reports $7.0 million revenue for fourth quarter 2010

HemaCare Corporation announced today that the Company generated fourth quarter revenue of $7.0 million and a net loss of $197,000, or $0.02/share, compared to fourth quarter 2009 revenue of $8.2 million and net income of $195,000, or $0.02/share.

14 Mar 2011

Dehaier Medical enters distribution agreement with Shanghai Haopu for eVent's inspiration ventilators

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has signed a distribution agreement with Shanghai Haopu Medical Instruments Co. Ltd. to become a regional distributor of eVent Medical's inspiration ventilator in the Chinese market.

14 Mar 2011

Shamir fourth quarter revenues increase 5.4% to $39.1 million

Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the fourth quarter and year ended December 31, 2010.

14 Mar 2011

Fysicon to customize Merge solutions for BeNeLux market

Merge Healthcare Incorporated, a global corporation dedicated to health IT interoperability solutions, today announced the expansion of its existing software relationship with Fysicon, the dominant Dutch distributor of medical imaging solutions for radiology and cardiology. Fysicon will customize Merge solutions to improve its specific portfolio of image management products for the BeNeLux market

14 Mar 2011

WaferGen Biosystems 2010 revenue exceeds guidance

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today reported financial results for the three months and year ended December 31, 2010.

14 Mar 2011